In order to verify the inhibitory effects of FAM225A on sorafenib sensitivity, we constructed a tumor xenograft model by subcutaneously injecting HepG2/SOR cells stably knockdown of FAM225A to nude mice. Here, FAM225A is linked to neoplasm.